Global Anti-Obesity Prescription Drugs Market Insights and Forecast to 2028

Report ID: 1802741 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Anti-Obesity Prescription Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Pediatric
        1.2.3 Adult
    1.3 Market by Application
        1.3.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 E-commerce
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Anti-Obesity Prescription Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Anti-Obesity Prescription Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Anti-Obesity Prescription Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Anti-Obesity Prescription Drugs Sales by Region
        2.4.1 Global Anti-Obesity Prescription Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Anti-Obesity Prescription Drugs by Region (2023-2028)
    2.5 Global Anti-Obesity Prescription Drugs Revenue by Region
        2.5.1 Global Anti-Obesity Prescription Drugs Revenue by Region (2017-2022)
        2.5.2 Global Anti-Obesity Prescription Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Anti-Obesity Prescription Drugs Sales by Manufacturers
        3.1.1 Global Top Anti-Obesity Prescription Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Obesity Prescription Drugs in 2021
    3.2 Global Anti-Obesity Prescription Drugs Revenue by Manufacturers
        3.2.1 Global Anti-Obesity Prescription Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Anti-Obesity Prescription Drugs Revenue in 2021
    3.3 Global Anti-Obesity Prescription Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Anti-Obesity Prescription Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Anti-Obesity Prescription Drugs Sales by Type
        4.1.1 Global Anti-Obesity Prescription Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Anti-Obesity Prescription Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Anti-Obesity Prescription Drugs Revenue by Type
        4.2.1 Global Anti-Obesity Prescription Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Anti-Obesity Prescription Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Anti-Obesity Prescription Drugs Price by Type
        4.3.1 Global Anti-Obesity Prescription Drugs Price by Type (2017-2022)
        4.3.2 Global Anti-Obesity Prescription Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Anti-Obesity Prescription Drugs Sales by Application
        5.1.1 Global Anti-Obesity Prescription Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Anti-Obesity Prescription Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Anti-Obesity Prescription Drugs Revenue by Application
        5.2.1 Global Anti-Obesity Prescription Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Anti-Obesity Prescription Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Anti-Obesity Prescription Drugs Price by Application
        5.3.1 Global Anti-Obesity Prescription Drugs Price by Application (2017-2022)
        5.3.2 Global Anti-Obesity Prescription Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Anti-Obesity Prescription Drugs Market Size by Type
        6.1.1 North America Anti-Obesity Prescription Drugs Sales by Type (2017-2028)
        6.1.2 North America Anti-Obesity Prescription Drugs Revenue by Type (2017-2028)
    6.2 North America Anti-Obesity Prescription Drugs Market Size by Application
        6.2.1 North America Anti-Obesity Prescription Drugs Sales by Application (2017-2028)
        6.2.2 North America Anti-Obesity Prescription Drugs Revenue by Application (2017-2028)
    6.3 North America Anti-Obesity Prescription Drugs Market Size by Country
        6.3.1 North America Anti-Obesity Prescription Drugs Sales by Country (2017-2028)
        6.3.2 North America Anti-Obesity Prescription Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Anti-Obesity Prescription Drugs Market Size by Type
        7.1.1 Europe Anti-Obesity Prescription Drugs Sales by Type (2017-2028)
        7.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Type (2017-2028)
    7.2 Europe Anti-Obesity Prescription Drugs Market Size by Application
        7.2.1 Europe Anti-Obesity Prescription Drugs Sales by Application (2017-2028)
        7.2.2 Europe Anti-Obesity Prescription Drugs Revenue by Application (2017-2028)
    7.3 Europe Anti-Obesity Prescription Drugs Market Size by Country
        7.3.1 Europe Anti-Obesity Prescription Drugs Sales by Country (2017-2028)
        7.3.2 Europe Anti-Obesity Prescription Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-Obesity Prescription Drugs Market Size by Type
        8.1.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Anti-Obesity Prescription Drugs Market Size by Application
        8.2.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Anti-Obesity Prescription Drugs Market Size by Region
        8.3.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Anti-Obesity Prescription Drugs Market Size by Type
        9.1.1 Latin America Anti-Obesity Prescription Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Anti-Obesity Prescription Drugs Revenue by Type (2017-2028)
    9.2 Latin America Anti-Obesity Prescription Drugs Market Size by Application
        9.2.1 Latin America Anti-Obesity Prescription Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Anti-Obesity Prescription Drugs Revenue by Application (2017-2028)
    9.3 Latin America Anti-Obesity Prescription Drugs Market Size by Country
        9.3.1 Latin America Anti-Obesity Prescription Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Anti-Obesity Prescription Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-Obesity Prescription Drugs Market Size by Type
        10.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Anti-Obesity Prescription Drugs Market Size by Application
        10.2.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Anti-Obesity Prescription Drugs Market Size by Country
        10.3.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 F Hoffmann La Roche Ltd
        11.1.1 F Hoffmann La Roche Ltd Corporation Information
        11.1.2 F Hoffmann La Roche Ltd Overview
        11.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 F Hoffmann La Roche Ltd Recent Developments
    11.2 Orexigen Therapeutics
        11.2.1 Orexigen Therapeutics Corporation Information
        11.2.2 Orexigen Therapeutics Overview
        11.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Orexigen Therapeutics Recent Developments
    11.3 Novo Nordisk A/s
        11.3.1 Novo Nordisk A/s Corporation Information
        11.3.2 Novo Nordisk A/s Overview
        11.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novo Nordisk A/s Recent Developments
    11.4 Arena Pharmaceuticals
        11.4.1 Arena Pharmaceuticals Corporation Information
        11.4.2 Arena Pharmaceuticals Overview
        11.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Arena Pharmaceuticals Recent Developments
    11.5 Glaxosmithkline
        11.5.1 Glaxosmithkline Corporation Information
        11.5.2 Glaxosmithkline Overview
        11.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Glaxosmithkline Recent Developments
    11.6 Vivus
        11.6.1 Vivus Corporation Information
        11.6.2 Vivus Overview
        11.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Vivus Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Vivus Recent Developments
    11.7 Boehringer Ingelheim
        11.7.1 Boehringer Ingelheim Corporation Information
        11.7.2 Boehringer Ingelheim Overview
        11.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Boehringer Ingelheim Recent Developments
    11.8 Alizyme
        11.8.1 Alizyme Corporation Information
        11.8.2 Alizyme Overview
        11.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Alizyme Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Alizyme Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Anti-Obesity Prescription Drugs Industry Chain Analysis
    12.2 Anti-Obesity Prescription Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-Obesity Prescription Drugs Production Mode & Process
    12.4 Anti-Obesity Prescription Drugs Sales and Marketing
        12.4.1 Anti-Obesity Prescription Drugs Sales Channels
        12.4.2 Anti-Obesity Prescription Drugs Distributors
    12.5 Anti-Obesity Prescription Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Anti-Obesity Prescription Drugs Industry Trends
    13.2 Anti-Obesity Prescription Drugs Market Drivers
    13.3 Anti-Obesity Prescription Drugs Market Challenges
    13.4 Anti-Obesity Prescription Drugs Market Restraints
14 Key Findings in The Global Anti-Obesity Prescription Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Pediatric
    Table 3. Major Manufacturers of Adult
    Table 4. Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Anti-Obesity Prescription Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Anti-Obesity Prescription Drugs Sales by Region (2017-2022) & (K Units)
    Table 7. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Anti-Obesity Prescription Drugs Sales by Region (2023-2028) & (K Units)
    Table 9. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Anti-Obesity Prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Anti-Obesity Prescription Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Anti-Obesity Prescription Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Anti-Obesity Prescription Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Anti-Obesity Prescription Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Anti-Obesity Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Prescription Drugs as of 2021)
    Table 21. Anti-Obesity Prescription Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Anti-Obesity Prescription Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Anti-Obesity Prescription Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 26. Global Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 27. Global Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
    Table 28. Global Anti-Obesity Prescription Drugs Sales Share by Type (2023-2028)
    Table 29. Global Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Anti-Obesity Prescription Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Anti-Obesity Prescription Drugs Revenue Share by Type (2023-2028)
    Table 33. Anti-Obesity Prescription Drugs Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Anti-Obesity Prescription Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 36. Global Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 37. Global Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
    Table 38. Global Anti-Obesity Prescription Drugs Sales Share by Application (2023-2028)
    Table 39. Global Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Anti-Obesity Prescription Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Anti-Obesity Prescription Drugs Revenue Share by Application (2023-2028)
    Table 43. Anti-Obesity Prescription Drugs Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Anti-Obesity Prescription Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. North America Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 47. North America Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 50. North America Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 51. North America Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 54. North America Anti-Obesity Prescription Drugs Sales by Country (2023-2028) & (K Units)
    Table 55. North America Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Anti-Obesity Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Anti-Obesity Prescription Drugs Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Anti-Obesity Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Anti-Obesity Prescription Drugs Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Anti-Obesity Prescription Drugs Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Anti-Obesity Prescription Drugs Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Anti-Obesity Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. F Hoffmann La Roche Ltd Corporation Information
    Table 106. F Hoffmann La Roche Ltd Description and Major Businesses
    Table 107. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. F Hoffmann La Roche Ltd Recent Developments
    Table 110. Orexigen Therapeutics Corporation Information
    Table 111. Orexigen Therapeutics Description and Major Businesses
    Table 112. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Orexigen Therapeutics Recent Developments
    Table 115. Novo Nordisk A/s Corporation Information
    Table 116. Novo Nordisk A/s Description and Major Businesses
    Table 117. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Novo Nordisk A/s Recent Developments
    Table 120. Arena Pharmaceuticals Corporation Information
    Table 121. Arena Pharmaceuticals Description and Major Businesses
    Table 122. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Arena Pharmaceuticals Recent Developments
    Table 125. Glaxosmithkline Corporation Information
    Table 126. Glaxosmithkline Description and Major Businesses
    Table 127. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Glaxosmithkline Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Glaxosmithkline Recent Developments
    Table 130. Vivus Corporation Information
    Table 131. Vivus Description and Major Businesses
    Table 132. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Vivus Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Vivus Recent Developments
    Table 135. Boehringer Ingelheim Corporation Information
    Table 136. Boehringer Ingelheim Description and Major Businesses
    Table 137. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Boehringer Ingelheim Recent Developments
    Table 140. Alizyme Corporation Information
    Table 141. Alizyme Description and Major Businesses
    Table 142. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Alizyme Anti-Obesity Prescription Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Alizyme Recent Developments
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Anti-Obesity Prescription Drugs Distributors List
    Table 148. Anti-Obesity Prescription Drugs Customers List
    Table 149. Anti-Obesity Prescription Drugs Market Trends
    Table 150. Anti-Obesity Prescription Drugs Market Drivers
    Table 151. Anti-Obesity Prescription Drugs Market Challenges
    Table 152. Anti-Obesity Prescription Drugs Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Obesity Prescription Drugs Product Picture
    Figure 3. Global Anti-Obesity Prescription Drugs Market Share by Type in 2021 & 2028
    Figure 3. Pediatric Product Picture
    Figure 4. Adult Product Picture
    Figure 5. Global Anti-Obesity Prescription Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Pharmacies
    Figure 7. Retail Pharmacies
    Figure 8. E-commerce
    Figure 9. Anti-Obesity Prescription Drugs Report Years Considered
    Figure 10. Global Anti-Obesity Prescription Drugs Sales 2017-2028 (K Units)
    Figure 11. Global Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Anti-Obesity Prescription Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Anti-Obesity Prescription Drugs Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Anti-Obesity Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Anti-Obesity Prescription Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Anti-Obesity Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Anti-Obesity Prescription Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Anti-Obesity Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Anti-Obesity Prescription Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Anti-Obesity Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Anti-Obesity Prescription Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Anti-Obesity Prescription Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Anti-Obesity Prescription Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Anti-Obesity Prescription Drugs in the World: Market Share by Anti-Obesity Prescription Drugs Revenue in 2021
    Figure 28. Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Anti-Obesity Prescription Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Anti-Obesity Prescription Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Anti-Obesity Prescription Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Anti-Obesity Prescription Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Anti-Obesity Prescription Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Anti-Obesity Prescription Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Anti-Obesity Prescription Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Anti-Obesity Prescription Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Anti-Obesity Prescription Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Anti-Obesity Prescription Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Anti-Obesity Prescription Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Anti-Obesity Prescription Drugs Value Chain
    Figure 87. Anti-Obesity Prescription Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Frequently Asked Questions
Anti-Obesity Prescription Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Obesity Prescription Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Obesity Prescription Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bio Simulation

Bio Simulation market is segmented by players, region (country), by Type and by Application. Play ... Read More

Biosimilar

Biosimilar market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More